以丘脑底核为靶点的脑深部电刺激治疗儿童泛酸激酶相关神经变性病
该研究回顾性分析了2016至2019年在本机构接受丘脑底核脑深部电刺激(STN-DBS)治疗的7例儿童泛酸激酶相关神经变性病(PKAN)患者。术后平均随访13.0±10.7个月,Burke-Fahn-Marsden肌张力障碍评定量表(BFMDRS)评分平均改善36.0±12.9分(P<0.001),百分比改善49.0±18.0%。作者认为STN-DBS是儿童PKAN有效的症状性治疗方法。
要点
- 7例儿童PKAN患者接受STN-DBS,术前平均BFMDRS评分为73.3±3.5。
- 术后平均随访13.0±10.7个月,BFMDRS评分平均改善36.0±12.9分(P<0.001)。
- BFMDRS评分百分比改善平均为49.0±18.0%。
核心结论
- 该病例系列表明,STN-DBS是儿童PKAN患者有效的症状性治疗方法。
研究设计与样本
- 回顾性分析了2016至2019年在本机构连续诊治的7例儿童PKAN患者,均接受STN-DBS治疗,并对每例进行详细描述。
主要发现
- 共纳入7例儿童患者,平均起病年龄为0.6±0.5岁,平均就诊年龄为6.6±1.3岁。
- 术前平均BFMDRS评分为73.3±3.5。
- 术后平均随访13.0±10.7个月,平均BFMDRS评分为37.3±12.6,评分平均改善36.0±12.9(P<0.001),百分比改善平均为49.0±18.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dystonia in pantothenate kinase-associated neurodegeneration (PKAN) is progressive despite medication. Deep brain stimulation (DBS) was reported to effectively provide symptom relief. No consensus exists in candidate and target selection for DBS. We aimed to demonstrate effectiveness of subthalamic DBS (STN-DBS) placement in pediatric patients with PKAN. METHODS: We reviewed consecutive series of pediatric patients diagnosed with PKAN and treated with STN-DBS from 2016 to 2019 in our institution. Each case was described in detail. Preoperative and postoperative Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) were assessed to evaluate functional improvement at follow-up. RESULTS: Seven pediatric patients were included. Mean age of initial onset was 0.6 ± 0.5 years and presentation to clinics was 6.6 ± 1.3 years. Mean preoperative BFMDRS was 73.3 ± 3.5. Following STN-DBS, for mean follow-up duration of 13.0 ± 10.7 months, mean BFMDRS was 37.3 ± 12.6, translating to score improvement of 36.0 ± 12.9 (P < 0.001), and percentage improvement of 49.0 ± 18.0%. CONCLUSIONS: This case series demonstrated that STN-DBS is an effective symptom-based treatment for pediatric patients with PKAN.
引用
- Li H, Li D, Yang W, et al. Deep Brain Stimulation (DBS) with Subthalamic Nucleus (STN) as Target for Pediatric Patients with PKAN. World Neurosurg. 2022. PMID: 35367641. doi:10.1016/j.wneu.2022.03.130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。